Compare MCHX & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCHX | CSBR |
|---|---|---|
| Founded | 2003 | 1985 |
| Country | United States | United States |
| Employees | N/A | 214 |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.3M | 65.4M |
| IPO Year | 2003 | 2015 |
| Metric | MCHX | CSBR |
|---|---|---|
| Price | $1.27 | $4.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 53.1K | 10.6K |
| Earning Date | 11-12-2026 | 09-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $90,291,000.00 | $2,900,000.00 |
| Revenue This Year | $17.69 | $9.83 |
| Revenue Next Year | $29.82 | $8.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.15 | $4.59 |
| 52 Week High | $2.00 | $8.31 |
| Indicator | MCHX | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 42.71 | 40.73 |
| Support Level | $1.19 | $4.59 |
| Resistance Level | $1.46 | $6.29 |
| Average True Range (ATR) | 0.09 | 0.17 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 30.00 | 2.17 |
Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.